Last updated: October 30, 2023
Sponsor: Our Lady of the Lake Hospital
Overall Status: Active - Recruiting
Phase
1
Condition
Hearing Loss
Ear Infections (Pediatric)
Otitis Media
Treatment
Sevoflurane inhalant product
Remifentanil Injection
Isoflurane Inhalant Product
Clinical Study ID
NCT05993039
TIVA in Ear Surgery
Ages < 100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Individuals of all ages
- Scheduled to undergo an endoscopic tympanoplasty
Exclusion
Exclusion Criteria:
- Individuals with anticoagulation disorders
- Those receiving anticoagulation therapy currently
Study Design
Total Participants: 100
Treatment Group(s): 4
Primary Treatment: Sevoflurane inhalant product
Phase: 1
Study Start date:
September 01, 2023
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Our Lady of the Lake Hospital
Baton Rouge, Louisiana 70808
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.